STD Diagnostics Market (By Product; By Application: HIV Testing, HSV Testing; By Technology; By Location Of Testing) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on STD Diagnostics Market 

5.1. COVID-19 Landscape: STD Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global STD Diagnostics Market, By Product

8.1. STD Diagnostics Market, by Product, 2023-2032

8.1.1. Instruments and Services

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Consumables

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Software

8.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global STD Diagnostics Market, By Application

9.1. STD Diagnostics Market, by Application, 2023-2032

9.1.1. CT/NG testing

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Syphilis testing

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Gonorrhea testing

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. HSV testing

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. HPV testing

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. HIV testing

9.1.6.1. Market Revenue and Forecast (2020-2032)

9.1.7. Ureaplasma & Mycoplasma testing

9.1.7.1. Market Revenue and Forecast (2020-2032)

9.1.8. Trichomonas

9.1.8.1. Market Revenue and Forecast (2020-2032)

9.1.9. VZV testing

9.1.9.1. Market Revenue and Forecast (2020-2032)

9.1.10. Others

9.1.10.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global STD Diagnostics Market, By Technology 

10.1. STD Diagnostics Market, by Technology, 2023-2032

10.1.1. Immunoassay

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Molecular Diagnostics

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Other

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global STD Diagnostics Market, By Location of Testing 

11.1. STD Diagnostics Market, by Location of Testing, 2023-2032

11.1.1. Laboratory Testing

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Point of Care Testing

11.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global STD Diagnostics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Forecast, by Technology (2020-2032)

12.1.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Forecast, by Technology (2020-2032)

12.2.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Forecast, by Technology (2020-2032)

12.3.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Forecast, by Technology (2020-2032)

12.4.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Forecast, by Technology (2020-2032)

12.5.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6.4. Market Revenue and Forecast, by Location of Testing (2020-2032)

Chapter 13. Company Profiles

13.1. BD

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche Ltd.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Hologic, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. bioMérieux SA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Abbott

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Danaher Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Qiagen

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Seegene Inc

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Thermo Fisher Scientific Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. DiaSorin S.p.A

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms